Linked Data API

Show Search Form

Search Results

428555
star this property registered interest false more like this
star this property date less than 2015-11-10more like thismore than 2015-11-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Drugs: Licensing more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what plans he has to improve the availability of off-patent drugs for novel uses through non-legislative measures. more like this
star this property tabling member constituency Glasgow North West more like this
star this property tabling member printed
Carol Monaghan more like this
star this property uin 902130 remove filter
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-11-17more like thismore than 2015-11-17
star this property answer text <p>Clinicians can already prescribe off-patent drugs off-label on clinical grounds if they judge this is the right thing to do to meet the individual clinical needs of their patients.</p><br /><p>The Government is keen to accelerate the adoption of innovative medicines and increase the innovative use of existing medicines where the evidence reports clinical benefits and cost effectiveness to patients. To that end, we are seeking a number of initiatives to provide innovation but whilst supporting the aims of the Private Member’s Bill on this subject, we do not believe the proposed mechanism is either practicable and desirable.</p><br /><p>We are working with NHS England, the National Institute for Health and Care Excellence, the General Medical Council and the Medicines and Health products Regulatory Agency to ensure that there is better information available to support clinicians who wish to prescribe off-patent drugs for off-label indications, and to ensure that new evidence is picked up more quickly and reliably and translated into clinical practice and can be fed through into licensing applications.</p><br /><p>A huge amount of work is also going on in the Accelerated Access Review which will support the “pull” of innovation through to clinical practice.</p><br /><p>As part of the debate on the Access to Medical Treatments Bill, we are working with officials in the Department, the Medicines and Healthcare products Regulatory Agency, and the Health and Social Care Information Centre to see how the power in the Bill, if it were to pass, could address the lack of provision of information on new uses for existing medicines via the power to create a database of innovations in order to support evidence-based prescribing.</p>
star this property answering member constituency Mid Norfolk more like this
star this property answering member printed George Freeman more like this
star this property grouped question UIN 902127 more like this
star this property question first answered
less than 2015-11-17T17:20:22.137Zmore like thismore than 2015-11-17T17:20:22.137Z
unstar this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4443
unstar this property label Biography information for Carol Monaghan remove filter